News

Abbott Laboratories CEO calls post-earnings stock decline ‘a little bit of an overreaction'
Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...
Abbott upgraded after post-earnings selloff, hardware drag seen temporary
Investing.com -- Jefferies upgraded Abbott Laboratories (NYSE: ABT) to Buy from Hold, calling the market reaction to the ...
Abbott Earnings Beat Forecasts. Why the Stock Is Having Its Worst Day Since 2021.
Abbott Laboratories stock tumbled Thursday after the maker of medical devices and nutrition products narrowed its full-year ...
Abbott Laboratories (ABT) Drops on Lower Full-Year Guidance
We recently published These 10 Stocks Just Lost Their Spark. Abbott Laboratories (NYSE:ABT) is one of the worst-performing ...
How Abbott Laboratories (ABT) Balances Innovation with Shareholder Payouts
Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. Abbott Laboratories (NYSE ...
Should You Buy Abbott Stock At $135?
Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...
Abbott’s Q2 revenue tops expectations but shares fall
Investing.com -- Abbott Laboratories reported second-quarter earnings that slightly exceeded analyst expectations, but shares ...
Crain's Chicago Business3d
Abbott falls on outlook cut, sees $200 million tariff impact
"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...
USA Today5y
Will Abbott Labs live up to coronavirus testing expectations? - USA TODAY
President Trump’s made-for-TV unboxing of Abbott Laboratories’ toaster-sized testing instrument beamed into millions of households last month as he displayed the unit in the Rose Garden. The ...